• Home
  • Contact Us
  • Try it!
  • Blog
  • Vizit Graphs

Follow us

Recent Posts

  • Biovista Harnesses New Kinds of Augmented and Artificial Intelligence to Address COVID-19 August 25, 2020
  • Repositioning Safety May 22, 2020
  • Artificial Intelligence firm Biovista repositions four promising therapeutics against COVID-19 April 22, 2020
  • Business Development Agent in Japan February 12, 2020
  • High Throughput Layout and Copy Paste July 5, 2019

Biovista Vizit

Biovista Vizit

  • Try it!
  • Blog
  • Vizit Graphs

TNF inhibitors and the microbiome

August 24, 2018Autoimmune Diseases, Microbiome, Vizit Graphs
TNF inhibitors and the microbiomeChristos Andronis2020-08-03T13:36:03+00:00
TNF inhibitors and the microbiome

Study microbiota of patients treated with TNF inhibitors with Biovista Vizit.

Explore the live graph.

Tags: ACTINOBACILLUS UREAE, CLOSTRIDIUM DIFFICILE, ENBREL, ESCHERICHIA COLI, FAECALIBACTERIUM PRAUSNITZII, HELICOBACTER PYLORI, HUMIRA, LISTERIA MONOCYTOGENES, PORPHYROMONAS GINGIVALIS, PSEUDOMONAS AERUGINOSA, REMICADE, STAPHYLOCOCCUS AUREUS, STREPTOCOCCUS PNEUMONIAE, STREPTOCOCCUS PYOGENES

Post navigation

← Psoriasis and RORgamma
Hepatitis and Autoimmune Diseases Drugs →

Vizit Graphs Tag Cloud

PSEUDOMONAS AERUGINOSA METFORMIN ACE2 ACE TNF IMMUNE RESPONSE IFNG IL2 ALBUMIN RAS PD-1 CASP3 AGING ALZHEIMER'S DISEASE INFLAMMATION TMPRSS2 IL10 COGNITION LACTATE DEHYDROGENASE SARS-COV-2 IL6 STAPHYLOCOCCUS AUREUS ANGIOTENSIN II MYALGIA NFKB1 RHEUMATOID ARTHRITIS CD4 ESCHERICHIA COLI PARKINSON DISEASE COAGULATION CELL DIFFERENTIATION INFLAMMATORY RESPONSE APOPTOTIC PROCESS CANCER IL1B NEUTROPHILS INTERFERON IMMUNITY CELL PROLIFERATION INSULIN COVID-19 LISTERIA MONOCYTOGENES CANDIDA ALBICANS HELICOBACTER PYLORI AUTOPHAGY

© 2021 Biovista Vizit All Rights Reserved.